Atypical presentation of Mycobacterium xenopi pulmonary infection in a kidney transplant recipient: A case report and literature review

被引:1
作者
Hamon, Antoine [1 ,4 ]
Liegeon, Geoffroy [1 ]
Louis, Kevin [2 ]
Cambau, Emmanuelle [3 ]
De Castro, Nathalie [1 ]
机构
[1] Paris C Univ, Hop St Louis, AP HP, Infect Dis Dept, 1 Ave Claude Vellefaux, F-75010 Paris, France
[2] Paris C Univ, Hop St Louis, AP HP, Nephrol & Renal Transplantat Dept, 1 Ave Claude Vellefaux, F-75010 Paris, France
[3] Paris C Univ, Hop Bichat, AP HP, Associate Lab,Natl Reference Ctr Mycobacteria & An, 46 Rue Henri Huchard, F-75018 Paris, France
[4] Paris C Univ, Hop St Louis, Infect Dis Dept, AP HP, Paris, France
来源
IDCASES | 2023年 / 31卷
关键词
Kidney transplantation; Mycobacterium xenopi; Non-tuberculous mycobacteria; TUBERCULOSIS; DISEASE;
D O I
10.1016/j.idcr.2022.e01675
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Mycobacterium xenopi is one of the most common pathogens responsible for non-tuberculosis mycobacteria (NTM) pulmonary diseases, which are associated with poor prognosis in immunocompromised patients.Case presentation: We report the unusual case of a 44-year-old kidney transplant recipient with multiple pul-monary nodules revealing M. xenopi pulmonary disease with atypical presentation. A three drug-regimen con-taining moxifloxacin, ethambutol and azithromycin was prescribed, with careful monitoring of the immunosuppressive therapy. The outcome was favorable. Discussion and conclusion: Although infrequent in kidney transplant recipients, NTM can cause pulmonary infection several years after transplantation. Treatment of M. xenopi infection relies on a multidrug regimen with at least 3 antimycobacterial drugs. Drug-drug interactions between immunosuppressive treatments and rifa-mycins require careful dose adjustment and monitoring to avoid graft rejection.
引用
收藏
页数:5
相关论文
共 20 条
  • [1] Mycobacterium xenopi pulmonary infections: a multicentric retrospective study of 136 cases in north-east France
    Andrejak, C.
    Lescure, F-X
    Pukenyte, E.
    Douadi, Y.
    Yazdanpanah, Y.
    Laurans, G.
    Schmit, J-L
    Jounieaux, V.
    [J]. THORAX, 2009, 64 (04) : 291 - 296
  • [2] Andrejak C, 2016, AM THORAC SOC, DOI [10.1164/ajrccm-conference.2016.193.1_MeetingAbstracts.A3733, DOI 10.1164/AJRCCM-CONFERENCE.2016.193.1_MEETINGABSTRACTS.A3733]
  • [3] Rifamycins - Obstacles and opportunities
    Aristoff, Paul A.
    Garcia, George A.
    Kirchhoff, Paul D.
    Showalter, H. D. Hollis
    [J]. TUBERCULOSIS, 2010, 90 (02) : 94 - 118
  • [4] Clinical features and outcomes of tuberculosis in transplant recipients as compared with the general population: a retrospective matched cohort study
    Benito, N.
    Garcia-Vazquez, E.
    Horcajada, J. P.
    Gonzalez, J.
    Oppenheimer, F.
    Cofan, F.
    Ricart, M. J.
    Rimola, A.
    Navasa, M.
    Rovira, M.
    Roig, E.
    Perez-Villa, F.
    Cervera, C.
    Moreno, A.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2015, 21 (07) : 651 - 658
  • [5] Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline: Executive Summary
    Daley, Charles L.
    Iaccarino, Jonathan M.
    Lange, Christoph
    Cambau, Emmanuelle
    Wallace, Richard J., Jr.
    Andrejak, Claire
    Bottger, Erik C.
    Brozek, Jan
    Griffith, David E.
    Guglielmetti, Lorenzo
    Huitt, Gwen A.
    Knight, Shandra L.
    Leitman, Philip
    Marras, Theodore K.
    Olivier, Kenneth N.
    Santin, Miguel
    Stout, Jason E.
    Tortoli, Enrico
    van Ingen, Jakko
    Wagner, Dirk
    Winthrop, Kevin L.
    [J]. CLINICAL INFECTIOUS DISEASES, 2020, 71 (04) : E1 - E36
  • [6] GEISELER PJ, 1985, AM REV RESPIR DIS, V131, P944
  • [7] The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples An NTM-NET collaborative study
    Hoefsloot, Wouter
    Van Ingen, Jakko
    Andrejak, Claire
    Angeby, Kristian
    Bauriaud, Rosine
    Bemer, Pascale
    Beylis, Natalie
    Boeree, Martin J.
    Cacho, Juana
    Chihota, Violet
    Chimara, Erica
    Churchyard, Gavin
    Cias, Raquel
    Daza, Rosa
    Daley, Charles L.
    Dekhuijzen, P. N. Richard
    Domingo, Diego
    Drobniewski, Francis
    Esteban, Jaime
    Fauvilte-Dufaux, Maryse
    Folkvardsen, Dorte Bek
    Gibbons, Noel
    Gomez-Mampaso, Enrique
    Gonzalez, Rosa
    Hoffmann, Harald
    Hsueh, Po-Ren
    Indra, Alexander
    Jagielski, Tomasz
    Jamieson, Frances
    Jankovic, Mateja
    Jong, Eefje
    Keane, Joseph
    Koh, Wo-Jung
    Lange, Bent
    Leao, Sylvia
    Macedo, Rita
    Mannsaker, Lurid
    Marras, Theodore K.
    Maugein, Jeannette
    Milburn, Heather J.
    Mlinko, Tannas
    Morcillo, Nora
    Morimoto, Kozo
    Papaventsis, Dimitrios
    Palenque, Elia
    Paez-Peria, Mar
    Piersimoni, Claudio
    Polanova, Monika
    Rastogi, Nalin
    Richter, Elvira
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2013, 42 (06) : 1604 - 1613
  • [8] Clarithromycin vs ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung diseases and an assessment of Mycobacterium vaccae immunotherapy
    Jenkins, P. A.
    Campbell, I. A.
    Banks, J.
    Gelder, C. M.
    Prescott, R. J.
    Smith, A. P.
    [J]. THORAX, 2008, 63 (07) : 627 - 634
  • [9] Jenkins PA, 2001, THORAX, V56, P167
  • [10] KOIZUMI JH, 1980, AM J CLIN PATHOL, V73, P826